INTRODUCTION
============

The skin is the most extensive tissue of the body and consists of three layers (epidermis, dermis, and subcutaneous tissue). The epidermis is a stratified squamous epithelium of the outermost layer, which provides a mechanical barrier against invasion of foreign substances and loss of body water. The epidermis mechanically maintains a skin structure against environmental stresses, including mechanical injury, UV radiation, and infection. Maintaining a constant skin structure requires dynamically coordinated degradation and synthesis of extracellular matrix (ECM) components.

Matrix metalloproteinases (MMPs) are a family of endopeptidases responsible for the proteolytic degradation of structural components of ECM. MMPs are associated with various physiological and pathological cellular functions, including cell migration, wound healing, angiogenesis, immune responses, cell growth and differentiation, apoptosis, and skin aging ([@ref1], [@ref2]). To date, at least 24 different MMPs have been identified in humans ([@ref1]) and classified into four groups based on their domain organization; archetypal MMPs, gelatinases, matrilysins, and furin-activatable MMPs ([@ref3]). Of archetypal MMPs, MMP-1 is a sub-group of collagenase involved in the initial cleavage of native fibrillar collagens ([@ref3]). It functions in tissue remodeling, inflammation, and skin photoaging ([@ref4]) and has been implicated in various pathological processes, such as tumor cell invasion, arthritis, and atherosclerosis ([@ref5]). Like other MMPs, MMP-1 is expressed at a low level in most normal cells but rapidly induced in response to exogenous signals, including growth factors, inflammatory cytokines, and oncogenic transformation. MMP-1 expression largely depends on transcriptional activity.

Wounds and other inflammatory responses in the skin lead to tissue remodeling characterized by elevated inflammatory cytokines. Tissue necrosis factor α (TNFα) is one of potent pro-inflammatory cytokine produced by dermal fibroblasts, monocytes/macrophages, and keratinocytes in response to ultraviolet irradiation and inflammatory signals ([@ref6]). TNFα promotes tissue remodeling by increasing the secretion of multiple cytokines and inflammatory mediators in keratinocytes and dermal fibroblasts ([@ref6]). MMP-1 is also induced by TNFα and contributes to the remodeling of damaged tissues ([@ref4]). The role of mitogen-activated protein kinases (MAPKs), including extracellular signal-regulated kinase (ERK), c-Jun-N-terminal kinase (JNK), and p38 kinase, is well established in the regulation of TNFα-induced MMP-1 expression via AP1 upregulation ([@ref3]).

Early Growth Response (EGR)-1 is an inducible zinc-finger transcription factor that binds to GC-rich sequences ([@ref7]). Generally, EGR-1 is expressed at the base level but is rapidly and transiently induced by various growth factors and inflammatory cytokines in a variety of cell types ([@ref8], [@ref9]). In turn, activated EGR-1 regulates the expression of many inflammation-related genes ([@ref10]-[@ref12]). Indeed, EGR-1 regulates interleukin (IL)-13-induced lung inflammation by expressing CC and CXC chemokines ([@ref13]) and TNFα-induced CXCL1 expression ([@ref8]). Furthermore, EGR-1 induces many pro-inflammatory cytokines in keratinocytes during skin inflammation; TNFα autoregulation ([@ref14]), IL-17A-induced psorian expression ([@ref15]), and IL-33-induced thymic stromal lymphopoietin (TSLP) expression ([@ref16]). We previously showed that EGR-1 transactivates the *MMP9* gene in response to TNFα stimulation in HeLa cells ([@ref17]). Although EGR-1 is induced by TNFα through MAPK pathways in diverse cell types ([@ref8], [@ref17], [@ref18]), the functional role of EGR-1 in the regulation of the *MMP1* gene promoter is not characterized.

We aimed to investigate the role of EGR-1 in the regulation of MMP-1 expression. The objective of this study is to identify the EGR-1-binding sites in the 5'-regulatory region of the *MMP-1* gene and to determine the molecular mechanisms involved in TNFα-induced MMP-1 expression in HaCaT keratinocyte model cell line. We demonstrated here that the EGR-1-binding motif is a positive *cis*-acting element necessary for the full-activation of TNFα-induced MMP-1 expression. Also, we showed that elevation of EGR-1 expression leads to the increase in *MMP1* gene promoter activity and that the silencing of EGR-1 by RNA interference abrogates TNFα-induced MMP-1 expression. We propose that EGR-1 is a potent transcription factor for regulating the *MMP1* gene transcription.

RESULTS AND DISCUSSION
======================

EGR-1-binding *cis*-acting element is necessary for TNFα-induced *MMP1* promoter activity
-----------------------------------------------------------------------------------------

The 5'-regulatory region of the *MMP1* gene contains multiple cis-acting elements; nuclear factor-kappa B (NF-kB), activator protein 1 (AP1), erythroblastosis twenty-six-1 (ETS-1), serum amyloid A-activating factor 1 (SAF1), and polyoma enhancer element A-3 (PEA-3), and signal transducer and activator of transcription sites (STAT3) ([@ref19], [@ref20]). In addition to these regulatory elements, we sought to find a new cis-acting element involved in TNFα-induced *MMP1* transcription. To characterize the regulatory regions responsible for TNFα stimulation, we constructed a series of 5' deletion constructs of the *MMP1* promoter (−569/+87, −356/+87, and −152/+87) in the luciferase-based reporter plasmid and mapped the active region responsible for TNFα stimulation ([Fig. 1A](#F1){ref-type="fig"}). Promoter reporter activity upon TNFα stimulation still occurred following the deletion of a region up to nucleotide position −151 bp, suggesting that the proximal region between −152 and +87 contains TNFα responsive *cis*-acting regulatory elements. We analyzed the transcription factor binding sites between −152 and +87 bp using a web-based MatInspector program (<http://www.genomatix.de/>). We found a putative EGR-1-binding sequence (EBS) located at −137/−119 near the AP1 site ([Supplementary Fig. S1](#S1){ref-type="supplementary-material"}).

To determine the role of the putative EBS in TNFα-induced MMP-1 expression, we disrupted EBS by site-specific deletion of core nucleotide (CTC). Disruption of the EGR-1-binding core sequence within the −152/+87 construct (mtEBS) resulted in a near-complete loss of TNFα-stimulated promoter-reporter activity (P \< 0.001, *n* = 3), compared to the wild-type construct ([Fig. 1B](#F1){ref-type="fig"}), suggesting that the EGR-1-binding motif at −137/−119 is necessary for TNFα-mediated *MMP1* transcription.

EGR-1 binds to the *MMP1* gene promoter
---------------------------------------

Next, we assessed whether EGR-1 binds to the putative EBS motif within the proximal *MMP1* promoter region. DNA binding was assessed using the electrophoretic mobility shift assay (EMSA) with Sf21 insect cell lysates overexpressing EGR-1 (Sf21/EGR-1). Biotinylated EBS oligonucleotides, but not mutated EBS (mtEBS), formed a DNA-protein complex ([Fig. 2A](#F2){ref-type="fig"}), suggesting that EGR-1 binds exclusively to the EBS motif within the proximal *MMP1* promoter region. EGR-1 binding to the EBS was confirmed using the DNA-affinity precipitation assay (DAPA). Biotinylated EBS and mtEBS oligonucleotides were incubated with nuclear extracts of HaCaT cells stimulated with TNFα or vehicle. After pull-down with streptavidin-conjugated agarose beads, oligonucleotide-binding proteins were eluted and immunoblotted using anti-EGR-1 antibodies. Similar to the EMSA result, TNFα stimulation increased EGR-1 binding to the EBS, but not to the mtEBS ([Fig. 2B](#F2){ref-type="fig"}), suggesting that EGR-1 directly interacts with the proximal EBS in the *MMP1* promoter region.

EGR-1 protein accumulated in a pattern similar to AP1 components (c-FOS and c-JUN) following TNFα stimulation in HaCaT cells ([Fig. 2C](#F2){ref-type="fig"}). To investigate whether EGR-1 alone could transactivate the *MMP1* promoter, we co-transfected EGR-1 expression plasmid and the −152/+87 promoter-reporter. The c-JUN component of AP1 was used as a positive control. Similar to c-JUN, exogenous EGR-1 expression elicited a significant DNA concentration-dependent increase in promoter activity of −152/+87 but not −152/+87mtEGR-1 ([Fig. 2D](#F2){ref-type="fig"}), suggesting EGR-1 is a positive regulator of the *MMP1* gene. Interestingly, disruption of the EBS (mtEBS) also abrogated c-JUN stimulation of promoter activity, suggesting that EGR-1 is also necessary for the AP1 *trans*-acting activity in *MMP1* transcription. As the Fos-Jun heterodimer interacts with EGR-1 in the promoter of the mouse *tyrosine hydroxylase* gene ([@ref21]), EGR-1 may directly or indirectly interact with AP1 to enhance *MMP1* promoter activity.

Knockdown of EGR-1 expression reduces TNFα-induced MMP-1 expression
-------------------------------------------------------------------

Upon TNFα stimulation, MMP-1 mRNA and protein levels were upregulated in a time-dependent manner in HaCaT cells ([Fig. 3A](#F3){ref-type="fig"}). To verify the role of EGR-1 in TNFα-induced MMP-1 expression, we established HaCaT variant cells expressing shRNAs against scrambled control (shCT) and EGR-1 (shEGR-1). shRNA-mediated knockdown of EGR-1 expression was confirmed by immunoblotting ([Fig. 3B](#F3){ref-type="fig"}). EGR-1 silencing reduced both basal and TNFα-induced MMP-1 mRNA and protein levels ([Fig. 3C](#F3){ref-type="fig"}). Thus, EGR-1 is necessary for TNFα-induced MMP-1 expression.

MAPK pathways mediate TNFα-induced MMP-1 expression via EGR-1 expression
------------------------------------------------------------------------

MAPK pathways regulate EGR-1 expression in various cell types ([@ref8],[@ref17], [@ref18],[@ref22]-[@ref25]). In serum-starved HaCaT cells, ERK1/2, p38, and JNK1/2 MAPK phosphorylation rapidly increased within 15 min following TNFα stimulation ([Fig. 4A](#F4){ref-type="fig"}), suggesting that TNFα activates three different MAPKs in HaCaT cells. To investigate the possible relationship between MAPK activation and EGR-1 upregulation, we examined the effects of pharmacological MAPK inhibitors on EGR-1 expression. MEK inhibitor U0126, JNK1/2 inhibitor SP600125, and p38 kinase inhibitor SB203580 significantly (P \< 0.001, *n* = 3) abrogated TNFα-induced c-JUN, c-FOS, and EGR-1 protein accumulation ([Fig. 4B](#F4){ref-type="fig"}). RT-PCR revealed considerable inhibition of MMP-1 mRNA expression by all three MAPK inhibitors ([Fig. 4C](#F4){ref-type="fig"}). To precisely quantify the effect of MAPK inhibition, we performed real-time PCR analysis. Upon TNFα stimulation, MMP-1 mRNA levels were enhanced 8.33 ± 2.52-fold, which was significantly reduced to 0.867 ± 0.252-, 0.333 ± 0.208-, and 0.600 ± 0.100-fold in the presence of U0126, SB203580, and SP600125, respectively ([Fig. 4D](#F4){ref-type="fig"}). These results suggest that all three major MAPKs are involved in TNFα-induced MMP-1 expression via EGR-1 induction.

In summary, EGR-1 is necessary for TNFα-induced MMP-1 expression in HaCaT keratinocytes. This study uncovered evidence of a novel EGR-1-binding cis-acting element located at −137/−119, which is necessary for TNFα-induced *MMP1* transcriptional activity. Although the role of EGR-1 in skin biology *in vivo*---wound healing and skin aging---needs further investigation, it might represent a valuable molecular target to develop new pharmaceutical agents to reduce inflammation-induced MMP-1 expression.

MATERIALS AND METHODS
=====================

Reagents
--------

TNFα, U0126, SB203580, and SP600125 were obtained from Calbiochem (San Diego, CA, USA). The Firefly and *Renilla* Dual-Glo^TM^ Luciferase Assay System were obtained from Promega (Madison, WI, USA). The pRL-null plasmid encoding *Renilla* luciferase was also purchased from Promega. Streptavidin-agarose was obtained from Invitrogen (Carlsbad, CA, USA). Antibodies against c-FOS, c-JUN, glyceraldehyde 3-phosphate dehydrogenase (GAPDH), and early growth response 1 (EGR-1) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Phospho-extracellular signal-activated kinase (ERK)1/2 (Thr202/Tyr204), phospho-p38 (Thr180/Tyr182), and phospho-c-jun N-terminal kinase (JNK)1/2 (Thr183/Tyr185) were obtained from Cell Signaling Technology (Danvers, MA, USA). Other chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA).

Cell culture
------------

HaCaT human keratinocytes were obtained from Cell Lines Service GmbH (Eppelheim, Germany). The cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS; BioWest, Kansas City, MO, USA).

Plasmids
--------

The pRL-null plasmid encoding *Renilla* luciferase was purchased from Promega. Plasmids expressing EGR-1 (pcDNA3.1/EGR-1) were described elsewhere ([@ref26]). Plasmids expressing c-JUN (pcDNA3.1/Jun) were obtained from Invitrogen.

Generation of serial deletion and mutant constructs of human MMP-1 gene promoter-reporter
-----------------------------------------------------------------------------------------

A human *MMP1* gene promoter fragment spanning nucleotides −569 to +87 was synthesized from human genomic DNA (Promega) by PCR using the primers 5'-TTG AAC TCC TGG GCT CAA GT-3' (forward: −569F) and 5'-CTG CTC CAA TAT CCC AGC TA-3' (reverse: +87R). The amplified PCR products were ligated into a T&A vector (RBC Bioscience, New Taipei City, Taiwan). Following digestion with *Kpn*I and *Bgl*II, the fragments into the *Kpn*I and *Bgl*II sites of the pGL4-basic vector (Promega). The fragment was ligated into the pGL4-Luc basic vector (Promega) to yield pMMP1-Luc (−569/+87). A series of deletion constructs were synthesized by PCR using the pMMP1-Luc (−569/+87) plasmid as a template. The forward primer sequences were 5'-TCA GTA CAG GTG CCG AAC AG-3' (−356F) and 5'-GGT GGT GGT ACC TGT TTA CAT GGC AGA GTG TGT C-3' (−152F). One reverse primer (+87R) was used to generate all deletion constructs. The amplified PCR products were ligated into the pGL4-Luc basic vector, yielding pMMP1-Luc (−356/+87) and pMMP1-Luc (−152/+87), respectively. Site-specific deletion of the EGR-1-binding sequence (mtEGR-1) was performed using the QuickChange site-directed mutagenesis system (Stratagene, La Jolla, CA, USA), with the pMMP1-Luc (−152/+87) construct as a template plasmid, yielding pMMP1-Luc (−152/+87) mtEGR-1. Primer sequences used to generate deletion mutants were as follows: mtEGR-1: forward, 5'-CTT CGC ACA CAT CTT GTT TGA AGT TAA TC-3'; reverse, 5'-AAG ACA CAC TCT GCC ATG TAA ACA G-3'. PCR conditions were 2 min at 94°C, followed by 25 cycles of denaturation at 94°C (30 s), annealing at 55°C (1 min), and elongation at 72°C (6 min). All reporter constructs and point mutation sites were verified by DNA sequencing at Macrogen (Seoul, Republic of Korea).

Luciferase promoter-reporter assay
----------------------------------

Reporter luciferase activity was measured as described previously ([@ref27]). In some experiments, pMMP1-Luc (−152/+87) and pMMP1-Luc (−152/+87)mtEGR-1 constructs were co-transfected with mammalian expression vectors for EGR-1 (pcDNA3.1/EGR-1) or c-Jun (pcDNA3.1/Jun). Luminescence was measured using a Centro LB960 dual luminometer (Berthold Tech, Bad Wildbad, Germany). The relative amount of luciferase activity after normalization to the *Renilla* luciferase signal in the untreated cells was designated as 1.

Expression of EGR-1 in Sf21 insect cells using the baculovirus system
---------------------------------------------------------------------

IPLB-Sf21 insect cells obtained from Clontech (Mountain View, CA, USA) were maintained in Grace's insect medium (Gibco, Grand Island, NY, USA) supplemented with 10% FBS (Hyclone, Logan, UT, USA), 100 U/ml penicillin, and 100 μg/ml streptomycin at 28°C. The coding DNA sequence of EGR-1 was obtained from the expression plasmid of EGR-1 (pcDNA3.1zeo/EGR-1) by digestion with *Hind*III and *Bgl*II and ligated into the same sites of the pOET1 Transfer Plasmid (Mirus Bio, Madison, WI, USA), yielding pOET1/EGR-1. IPLB-Sf21 cells were plated into the wells of a 6-well plate at a density of 1.5 × 10^6^ cells/well and incubated for 1 h. Each well then received 100 ng of transfer vector (pOET/EGR-1), 100 ng viral DNA (*flash*BAC^TM^, Mirus Bio), and 1.2 μl of *Trans*IT^Ⓡ^-Insect Transfection Reagent (Mirus Bio) in 100 μl serum-free Grace's insect medium. The plates were incubated for 20 min after gently pipetting. The mixture was added dropwise, and the plates were incubated at 28°C for 4 to 5 days. The cells were dislodged from each well into the fluid by scraping and collected by centrifugation. The transfected EGR-1 level was confirmed using immunoblotting.

Electrophoretic mobility shift assay (EMSA)
-------------------------------------------

Protein-DNA binding was assessed by EMSA using the LightShift Chemiluminescence EMSA kit, according to the manufacturer's instructions (ThermoFisher Scientific, Waltham, MA, USA). Biotin-labeled deoxyoligonucleotide probes corresponding to the EGR-1-binding sequence (EBS; 5'-biotin-AGA GTG TGT CTC CTT CGC ACA CAT C-3') and mutated sequence (mtEBS; 5'-biotin-AGA GTG TGT CTT CGC ACA CAT C-3') were synthesized by Macrogen. Wild-type control or EGR-1-expressing IPLB-Sf21 lysates (3 μg) were mixed with 50 fmol biotin-labeled EBS and mtEBS oligonucleotide probes along with 1 μg poly(dI-dC) (Amersham Pharmacia Biotech Inc., Piscataway, NJ, USA). Samples were electrophoresed in non-denaturing 6% polyacrylamide gels, followed by incubation with horseradish peroxidase (HRP)-conjugated streptavidin. EGR-1-DNA complexes were visualized using an enhanced chemiluminescence (ECL) detection system (ThermoFisher Scientific).

Immunoblot analysis
-------------------

HaCaT cells treated with PBS or 10 ng/ml TNFα were lysed and immunoblot analysis was performed as described previously ([@ref8]). The blots were developed using LumiGLO peroxidase chemiluminescent substrate (SeraCare, Milford, MA, USA). In some experiments, the relative intensities of the MMP-1 bands were quantified and normalized by GAPDH expression using ImageJ version 1.52a software (National Institutes of Health, Bethesda, MD, USA).

DNA-affinity precipitation assay (DAPA)
---------------------------------------

HaCaT cells were stimulated with 10 ng/ml TNFα for 12 h, and nuclear extracts (70 μg) were incubated with streptavidin-conjugated magnetic beads (BIONEER, Daejeon, Korea) and 5 μg of biotinylated EBS (5'-biotin-AGA GTG TGT CTC CTT CGC ACA CAT C-3') or mtEBS (5'-biotin-AGA GTG TGT CTT CGC ACA CAT C-3') for 15 min. After washing twice with PBS, the pellets were cooked with Laemmli sample buffer, and the binding proteins were resolved by 10% SDS-PAGE. Immunoblotting was performed using anti-EGR-1 antibodies.

Reverse transcription-polymerase chain reaction (RT-PCR)
--------------------------------------------------------

Isolation of total RNA and synthesis of complementary DNA (cDNA) were described elsewhere ([@ref27]). The resulting cDNA was subjected to PCR analysis using gene-specific primers as follows: forward MMP-1, 5'-CAA AAT CCT GTC CAG CCC ATC G-3' and reverse MMP-1, 5'-TTC GTA AGC AGC TTC AAG CCC-3'; forward GAPDH, 5'-ACC CAC TCC TCC ACC TTT G-3' and reverse GAPDH, 5'-CTC TTG TGC TGC TGG G-3'. The PCR conditions included denaturation at 95°C for 30 s, annealing at 62°C for 30 s, and elongation at 72°C for 30 s. The amplicons were electrophoresed on 1% agarose gels and visualized by ethidium bromide staining. In some experiments, relative intensities of MMP-1 PCR bands were quantified and expressed as a ratio to GAPDH intensities using ImageJ version 1.52a software.

Knockdown of EGR-1 by using shRNA
---------------------------------

HaCaT cells were incubated with lentiviral short hairpin (sh)RNA (TRCN_0000273850; MISSION^Ⓡ^ shRNA; Sigma-Aldrich) targeting EGR-1, according to the manufacturer's instructions. Two weeks after transfection, cells were collected, and the stable knockdown of EGR-1 expression was analyzed by immunoblotting.

Statistical analyses
--------------------

Data were analyzed by ANOVA, followed by Sidak's or Dunnett's multiple comparisons test, using GraphPad Prism version 8.2.0 software (GraphPad Software Inc., La Jolla, CA, USA). P-values less than 0.05 were considered statistically significant.
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![The EGR-1-binding sequence in the MMP1 promoter is functional. (A) HaCaT cells were transfected with 0.1 μg of a series of 5'-deletion constructs of MMP-1 promoter-reporter (pMMP1-Luc). After 48 h, the cells were treated with either vehicle (PBS) or 10 ng/ml TNFα and incubated for an additional 8 h; subsequently, luciferase activities were determined. Bars represent the mean ± S.D. (*n* = 3). \*\*P \< 0.001; NS, not significant; by Sidak's multiple comparison test. (B) HaCaT cells were transfected with 0.1 μg of wild-type (WT) pMMP1-Luc (−152/+87) or EGR-1 site mutant construct (mtEGR-1). After 48 h, cells were treated with either vehicle (PBS) or 10 ng/ml TNFα for an additional 8 h; subsequently, luciferase activities were determined. Bars represent the mean ± S.D. (*n* = 3). \*\*P \< 0.001; NS, not significant; by Sidak's multiple comparison test.](BMB-53-323-f1){#F1}

![EGR-1 transactivates the *MMP1* promoter. (A) Biotinylated EGR-1-binding sequence probe (EBS) or mutated EBS (mtEBS) was incubated with increasing concentrations of the Sf21 cell lysates expressing EGR-1 (Sf21/EGR-1) or WT (Sf21/Cont). Samples were separated by non-denaturing 6% acrylamide gel electrophoresis and visualized using streptavidin-conjugated horseradish peroxidase. (B) HaCaT cells were treated with 10 ng/ml TNFα for 1 h. Nuclear extracts were prepared and incubated with biotinylated EBS or mtEBS for 1 h, followed by precipitation with streptavidin-conjugated agarose beads. Immunoblotting was performed with an anti-EGR-1 antibody and analyzed by the DNA-affinity precipitation assay. (C) HaCaT cells were treated with 10 ng/ml TNFα for different periods (0-240 min). Cell lysates were immunoblotted with antibodies against EGR-1, c-FOS, and c-JUN. GAPDH levels were examined as an internal control. (D) HaCaT cells were co-transfected 0.1 μg of wild-type (−152/+87) or EGR-1 site mutant construct (−152/+87 mtEGR-1) with 50 or 100 ng of an expression plasmid for EGR-1 or c-JUN. After 48 h, luciferase activities were measured. Bars represent the mean ± SD (*n* = 3). Bars represent the mean ± S.D. (*n* = 3). \*P = 0.0336; \*\*P \< 0.001; NS, not significant; by Sidak's multiple comparison test.](BMB-53-323-f2){#F2}

![Effect of EGR-1 silencing on TNFα-induced MMP-1 expression. (A) HaCaT cells were treated with 10 ng/ml TNFα for various times (0-24 h). MMP-1 mRNA and protein levels were determined by RT-PCR and immunoblot, respectively. GAPDH levels were examined as an internal control. (B, C) HaCaT variant cells expressing scrambled (shCT) or EGR-1 shRNA (shEGR-1) were treated with 10 ng/ml TNFα for 1 h (for EGR-1) or 12 h (for MMP-1). GAPDH levels were examined as an internal control. The band intensities of MMP-1 relative to GAPDH were measured using ImageJ software. Bars represent the mean ± S.D. (*n* = 3). \*\*P = 0.0026; \*\*\*P \< 0.001; \*\*\*\*P \< 0.0001; NS, not significant; by Sidak's multiple comparison test.](BMB-53-323-f3){#F3}

![Role of MAPKs in EGR-1-mediated MMP-1 expression by TNFα. (A) HaCaT cells were treated with 10 ng/ml TNFα for various times (0-240 min). Immunoblotting was performed using a phospho-specific antibody against ERK1/2 (Thr202/Tyr204), p38 (Thr180/Tyr182), or JNK1/2 (Thr183/Tyr185) MAPK. GAPDH levels were examined as an internal control. (B) HaCaT cells were pre-treated with U0126 (10 μM), SB203580 (20 μM), or SP600125 (20 μM) for 30 min before stimulation with 10 ng/ml TNFα. After 30 (for c-JUN) or 60 min (for c-FOS and EGR-1) of TNFα treatment, immunoblotting was performed with indicated antibodies. GAPDH levels were examined as an internal control. (C and D) HaCaT cells were pre-treated with U0126 (10 μM), SB203580 (20 μM), or SP600125 (20 μM) for 30 min before stimulation with 10 ng/ml TNFα. After 12 h of TNFα treatment, RT-PCR (C) and real-time PCR (D) were performed. GAPDH levels were examined as an internal control. The band intensities were measured as relative to GAPDH using ImageJ software. Bars represent the mean ± S.D. (*n* = 3). \*\*\*P \< 0.0001 by Sidak's multiple comparison test.](BMB-53-323-f4){#F4}
